QC
NVAX icon

Quadrature Capital’s Novavax NVAX Stock Holding History

Quadrature Capital’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$508K Buy
+53,891
New +$483K ﹤0.01% 1003
2026
Q1 		– Sell
-20,226
Closed -$136K – 1710
2025
Q4 		$136K Sell
20,226
-20,962
-51% -$158K ﹤0.01% 1046
2025
Q3 		$357K Buy
41,188
+10,867
+36% +$84.6K ﹤0.01% 623
2025
Q2 		$191K Buy
+30,321
New +$201K ﹤0.01% 820

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Quadrature Capital's NVAX Position: Q2 2026 in Review

Quadrature Capital opened a new position in Novavax (NVAX) in Q2 2026: 53,891 shares worth $508K. The stake represents ﹤0.01% of the portfolio and ranks #1003 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in NVAX as recently as Q4 2025.

Quadrature Capital first reported a position in NVAX in Q2 2025 and has held it in 4 quarters since. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Quadrature Capital held 53,891 shares of Novavax worth $508K as of Q2 2026.
  • Novavax was a new Quadrature Capital position in Q2 2026.
  • Novavax made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1003 holding.
  • Quadrature Capital first reported a position in Novavax in Q2 2025 and has held it in 4 quarters since.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.